Kjell M. Tveit - Publications

Early-onset colorectal cancer incidence in Norway: a national registry-based study (1993-2022) analyzing subsite and morphology trends.

Journal: ESMO gastrointestinal oncology

Published: August 02, 2024

Inclusion in the cancer patient pathway among cancer patients with and without pre-existing mental or substance use disorders: a nationwide register-based study.

Journal: BMC public health

Published: February 05, 2024

Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS-/BRAF-Mutated Metastatic Colorectal Cancer.

Journal: Clinical colorectal cancer

Published: March 11, 2023

Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: February 03, 2022

Equitable access to cancer patient pathways in Norway - a national registry-based study.

Journal: BMC health services research

Published: September 09, 2021

Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: May 04, 2021

Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer.

Journal: International journal of cancer

Published: December 02, 2020

Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 03, 2019

Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.

Journal: Annals of internal medicine

Published: May 01, 2018

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome.

Journal: British journal of cancer

Published: September 29, 2017

Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 27, 2017

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study.

Journal: British journal of cancer

Published: January 24, 2017